These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 7500284

  • 1. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates.
    Yoshioka M, Hancock BC, Zografi G.
    J Pharm Sci; 1995 Aug; 84(8):983-6. PubMed ID: 7500284
    [Abstract] [Full Text] [Related]

  • 2. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
    Matsumoto T, Zografi G.
    Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278
    [Abstract] [Full Text] [Related]

  • 3. The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state.
    Crowley KJ, Zografi G.
    Pharm Res; 2003 Sep; 20(9):1417-22. PubMed ID: 14567636
    [Abstract] [Full Text] [Related]

  • 4. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX, Anderson BD.
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [Abstract] [Full Text] [Related]

  • 5. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC, Marsac PJ, Stanford LA, Taylor LS.
    Mol Pharm; 2009 Mar; 6(5):1492-505. PubMed ID: 19634917
    [Abstract] [Full Text] [Related]

  • 6. Effects of molecular weight of polyvinylpyrrolidone on the glass transition and crystallization of co-lyophilized sucrose.
    Zeng XM, Martin GP, Marriott C.
    Int J Pharm; 2001 May 07; 218(1-2):63-73. PubMed ID: 11337150
    [Abstract] [Full Text] [Related]

  • 7. Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid, and PVP.
    Lu Q, Zografi G.
    Pharm Res; 1998 Aug 07; 15(8):1202-6. PubMed ID: 9706050
    [Abstract] [Full Text] [Related]

  • 8. Anti-plasticizing effect of amorphous indomethacin induced by specific intermolecular interactions with PVA copolymer.
    Ueda H, Aikawa S, Kashima Y, Kikuchi J, Ida Y, Tanino T, Kadota K, Tozuka Y.
    J Pharm Sci; 2014 Sep 07; 103(9):2829-2838. PubMed ID: 24890320
    [Abstract] [Full Text] [Related]

  • 9. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.
    Yoshioka M, Hancock BC, Zografi G.
    J Pharm Sci; 1994 Dec 07; 83(12):1700-5. PubMed ID: 7891297
    [Abstract] [Full Text] [Related]

  • 10. Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction.
    Newman A, Engers D, Bates S, Ivanisevic I, Kelly RC, Zografi G.
    J Pharm Sci; 2008 Nov 07; 97(11):4840-56. PubMed ID: 18351626
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of absorbed water on the properties of amorphous mixtures containing sucrose.
    Shamblin SL, Zografi G.
    Pharm Res; 1999 Jul 07; 16(7):1119-24. PubMed ID: 10450941
    [Abstract] [Full Text] [Related]

  • 14. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
    Aso Y, Yoshioka S, Kojima S.
    J Pharm Sci; 2004 Feb 07; 93(2):384-91. PubMed ID: 14705195
    [Abstract] [Full Text] [Related]

  • 15. Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers.
    Khougaz K, Clas SD.
    J Pharm Sci; 2000 Oct 07; 89(10):1325-34. PubMed ID: 10980507
    [Abstract] [Full Text] [Related]

  • 16. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V, Tajber L, Corrigan OI, Healy AM.
    Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367
    [Abstract] [Full Text] [Related]

  • 17. Formation and characterization of porous indomethacin-PVP coprecipitates prepared using solvent-free supercritical fluid processing.
    Gong K, Viboonkiat R, Rehman IU, Buckton G, Darr JA.
    J Pharm Sci; 2005 Dec 04; 94(12):2583-90. PubMed ID: 16258991
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.